Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > The evidence is clear

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on May 22, 2024 3:47pm

85 Views

Post# 36052645

RE:RE:RE:RE:RE:The evidence is clear

Again, every accusation is a confession. I'm a horrible person yet you are just here to watch someone be upset? What has canadafan ever done to you?

I've seen your stock picks, you could decorate a 5 bedroom house with your wallpaper.

If you're so weak to be pulled in to a stock by someone else's DD you deserve every bit of your failure. Take responsibility for your own mistakes.

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals